HK1125824A1 - 幹細胞的 分化和生長 - Google Patents

幹細胞的 分化和生長

Info

Publication number
HK1125824A1
HK1125824A1 HK09103540.0A HK09103540A HK1125824A1 HK 1125824 A1 HK1125824 A1 HK 1125824A1 HK 09103540 A HK09103540 A HK 09103540A HK 1125824 A1 HK1125824 A1 HK 1125824A1
Authority
HK
Hong Kong
Prior art keywords
mntf
differentiation
growth
stem cells
stem
Prior art date
Application number
HK09103540.0A
Other languages
English (en)
Inventor
．德施潘德
．科爾
．寇
Original Assignee
健能萬生物制藥公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 健能萬生物制藥公司 filed Critical 健能萬生物制藥公司
Publication of HK1125824A1 publication Critical patent/HK1125824A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
HK09103540.0A 2005-11-10 2009-04-17 幹細胞的 分化和生長 HK1125824A1 (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US73570205P 2005-11-10 2005-11-10
US84176606P 2006-09-01 2006-09-01
US85802206P 2006-11-10 2006-11-10
PCT/US2006/043874 WO2007058982A2 (en) 2005-11-10 2006-11-10 Mntf differentiation and growth of stem cells

Publications (1)

Publication Number Publication Date
HK1125824A1 true HK1125824A1 (zh) 2009-08-21

Family

ID=38049179

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09103540.0A HK1125824A1 (zh) 2005-11-10 2009-04-17 幹細胞的 分化和生長

Country Status (8)

Country Link
US (1) US8986676B2 (zh)
EP (1) EP1965826B1 (zh)
JP (2) JP5270362B2 (zh)
CN (1) CN101374537B (zh)
AU (1) AU2006315668B2 (zh)
CA (1) CA2626728A1 (zh)
HK (1) HK1125824A1 (zh)
WO (1) WO2007058982A2 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2028268A1 (en) * 2007-08-20 2009-02-25 Université Libre De Bruxelles Generation of neuronal cells from pluripotent stem cells
WO2009105780A2 (en) * 2008-02-21 2009-08-27 Genervon Biopharmaceuticals Llc Mntf peptide compositions and methods of use
US20120142005A1 (en) * 2009-05-26 2012-06-07 Takeda Pharmaceutical Company Limited Method for screening of regenerative medicine
US9770471B2 (en) 2011-08-17 2017-09-26 President And Fellows Of Harvard College Conversion of somatic cells into functional spinal motor neurons, and methods and uses thereof
CN104379731A (zh) * 2011-11-04 2015-02-25 纪念斯隆-凯特琳癌症中心 用于植入的中脑多巴胺(da)神经元
CN104073468B (zh) * 2014-07-16 2016-04-27 栾佐 获得人源OPCs的方法和OPCs培养基
WO2016076102A1 (ja) 2014-11-14 2016-05-19 株式会社リジェネシスサイエンス 軟骨細胞の無血清培養方法，及び無血清培地
WO2016210123A1 (en) 2015-06-26 2016-12-29 Genervon Biopharmaceuticals, LLC Methods of using gm604 in modulating als disease biomarkers leading to prognosis and therapeutic treatment for als disease
CN110381981A (zh) * 2016-12-23 2019-10-25 健能万生物制药公司 在诊断和治疗阿尔茨海默病中使用gm6的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US6309877B1 (en) 1996-09-27 2001-10-30 Km Biotech, Inc. Polynucleotides encoding motoneuronotrophic factors
US6841531B2 (en) * 1996-09-27 2005-01-11 Genervon Biopharmaceuticals Llc Methods and use of motoneuronotrophic factors
US6300117B1 (en) 1997-09-15 2001-10-09 Genencor International, Inc. Proteases from gram-positive organisms
AU6319901A (en) 2000-05-17 2001-11-26 Geron Corp Neural progenitor cell populations
US7390659B2 (en) * 2002-07-16 2008-06-24 The Trustees Of Columbia University In The City Of New York Methods for inducing differentiation of embryonic stem cells and uses thereof
CA2506855C (en) * 2003-01-21 2013-08-27 Genervon Biopharmaceuticals Llc Mntf peptides and compositions and methods of use
AU2004290086A1 (en) * 2003-11-07 2005-05-26 Genervon Biopharmaceuticals Llc Motoneuronotrophic factor gene sequences

Also Published As

Publication number Publication date
CA2626728A1 (en) 2007-05-24
US8986676B2 (en) 2015-03-24
AU2006315668A1 (en) 2007-05-24
AU2006315668B2 (en) 2013-06-20
JP5270362B2 (ja) 2013-08-21
US20090117085A1 (en) 2009-05-07
CN101374537A (zh) 2009-02-25
EP1965826B1 (en) 2014-12-31
JP2013177388A (ja) 2013-09-09
WO2007058982A3 (en) 2008-09-25
EP1965826A2 (en) 2008-09-10
EP1965826A4 (en) 2010-08-25
WO2007058982A2 (en) 2007-05-24
CN101374537B (zh) 2016-04-20
JP2009515891A (ja) 2009-04-16

Similar Documents

Publication Publication Date Title
IL184964A0 (en) Directed differentiation of embryonic stem cells and uses thereof
GB2441488B (en) Suspension culture of human embryonic stem cells
EP1730261A4 (en) COMPOSITIONS AND METHODS FOR GROWING EMBRYONIC STEM CELLS
HK1125824A1 (zh) 幹細胞的 分化和生長
SG138570A1 (en) Growth of embryonic stem cells
GB2441718B (en) Differentiation of human embryonic stem cells to cardiomyocyte-lineage cells
IL181438A0 (en) Culturing human embryonic stem cells
GB0803474D0 (en) Compositions and methods for growth of pluripotent cells
GB2431165B (en) Medium for growing human embryonic stem cells
IL180437A0 (en) Shape and dimension maintenance of soft tissue grafts by stem cells
IL197684A0 (en) Stem cell culture medium and methods of use thereof
IL178232A0 (en) Methods for growing pluripotent stem cells
GB0707395D0 (en) Cultivation of primate embryonic stem cells
ZA200804718B (en) Co-culture of placental stem cells and stem cells from a second source
EP2089510A4 (en) STEM CELLS FROM THE AMNION AND USES THEREOF
GB2429211B (en) Feeder independent extended culture of embryonic stem cells
HK1207883A1 (zh) 細胞的培養方法及其應用
EP1743025A4 (en) METHOD OF MANUFACTURING REGULATOR T CELLS AND THEIR USE
EP1838724A4 (en) STEM CELL FACTOR PROTEINS AND USES THEREOF
EP1888741A4 (en) TREATMENT OF ISCHEMIA WITH STEM CELLS
EP1942926A4 (en) STEM CELL FACTOR ARTIFICIAL PROTEIN SCFA1 AND ITS USES
EP1917348A4 (en) ISOLATION OF MULTIPLE LINE STEM CELLS
ZA200805210B (en) Methods of improving stem cell homing and engraftment
GB201002469D0 (en) Parthenote-derived stem cells and methods of making and using them
EP1758987A4 (en) METHODS FOR EXPANSION AND DIFFERENTIATION OF STEM CELLS

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20211108